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We have developed a graphene oxide (GO)-based nanoplatform simultaneously loaded with a chemical
drug and Ag nanoparticles (NPs), and employed it to study the drug release from GO in living cells by
surface-enhanced Raman spectroscopy (SERS). In our strategy, doxorubicin (DOX), a typical model
anticancer drug, was loaded onto chemically prepared GO by means of p–p stacking, while the Ag NPs
were covalently modified onto GO. After incubation of the DOX- and Ag NPs-loaded GO with Ca Ski
cells for several hours, DOX will detach from the GO in an acidic environment due to the pH-dependent
p–p interaction between DOX and GO. Real-time measurement of SERS signals of DOX using the GO
loaded with Ag NPs as a SERS-active substrate allows us to monitor the process of the drug release
inside the living cell. The SERS results reveal that DOX is initially released from the GO surface inside the
lysosomes, then escapes into the cytoplasm, and finally enters the nucleus, while GO, the nanocarrier,
remains within the cytoplasm, without entering the nucleus.1 Introduction
The development of nanoscale drug delivery systems has
become a hot research eld in nanomedicine because they can
offer efficient and targeted drug transportation to specic
disease sites, so as to reduce drug dosage and the severity of
toxic side effects. Graphene oxide (GO) exhibits large surface
area,1 good biocompatibility and low toxicity aer proper
functionalization,2,3 an ultrahigh drug loading ratio,4 and has
thereby become an ideal nanocarrier for drug delivery.2–4
Doxorubicin (DOX) is a typical anti-cancer drug widely used in
the treatment of many malignant diseases because of its broad
antitumor activity.5,6 Our previous work indicated that DOX can
be efficiently loaded onto the GO surface byp–p stacking, with a
loading ratio up to 400%.4 The DOX molecules will detach from
GO under acidic conditions because of the pH-dependent p–p
stacking interaction between DOX and GO.1,7 However, the
precise process of drug release from GO inside the living cell
has not been fully studied yet. Revealing this process is
important to understand the mechanism of chemotherapy ande, Division of Nanobiomedicine, Suzhou
Chinese Academy of Sciences, Suzhou
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Chemistry 2013for the design of novel, more efficient GO-based drug delivery
systems.
The uorescence technique has been used to monitor the
drug delivery process.8,9 However, uorescent organic dye
labeling has intrinsic limitations such as a broad uorescence
band, photo-bleaching, and interference from cellular auto-
uorescence. In TEM measurement, cells have to be sliced in
the sampling process. Surface-enhanced Raman spectroscopy
(SERS) has attracted considerable interest in life science due to
it being non-destructive, showing resistance to photobleaching,
narrow emission bands and ultrasensitive features.10–12 SERS
provides a “molecular ngerprint” that can be used to identify a
molecule or verify its presence with its intrinsic signals in a
sample, cell, or cellular compartment. SERS can enhance the
Raman signals of target species adsorbed on Ag or Au metallic
nanostructures by as much as 6–14 orders of magnitude, which
even allows the detection of single molecules.13–15 With these
excellent advantages, SERS has previously been used to detect
the diffusion, cellular uptake and dynamics of drugs in living
cells,16,17 which demonstrates that SERS is capable of obtaining
dynamic information of drug molecules in living cells. In our
previous work,18 we prepared Au NPs–GO composites via
chemical conjugation, and observed strong SERS peaks of GO at
1330 cm1 and 1600 cm1 in living cells. In addition, we showed
that the introduction of Au NPs onto the GO surface led to a
signicantly enhanced Raman signal of GO in living cells,
compared to that with isolated GO.18
In this work, we designed a GO-based nanoplatform onto
which the drug molecules and Ag nanoparticles (NPs) were
loaded by p–p stacking and covalent conjugation, respectively.













































View Article Onlinesubstrate, due to themuch higher SERS enhancement of Ag NPs
than Au NPs,19 which will be better for detecting the Raman
signals of DOX within cells. Here GO acts as a vehicle for
loading and delivery of the Ag NPs and DOX into the cells.
Through in situ detection of the SERS signals of DOX, and in
combination with uorescence microscopy, we investigated the
release prole of DOX from GO inside living cells. Our results
suggest that DOX was rstly detached from GO inside the
lysosomes, escaped into the cytoplasm, and nally entered the
nucleus; by contrast, GO was retained in the cytoplasm without
entering the nucleus. Compared with the uorescence tech-
nique, SERS allows a simple, rapid, non-destructive and direct




Native graphite akes were purchased from Alfa Aesar;meso-2,3-
dimercaptosuccinic acid (DMSA), amine-terminated six-armed
PEG, EDC, Lyso-Tracker Green, Lyso-Tracker Red and uo-
rescein isothiocyanate (FITC) were purchased from Sigma;
AgNO3, trisodium citrate, NaOH and other reagents were
purchased from China National Medicine Corporation and
used as received.
2.2 Preparation and DMSA modication of Ag NPs
20 nm Ag NPs were prepared according to the approach of Lee
and Meisel.20 Briey, AgNO3 aqueous solution (100 mL, 5.30 
104 M) was heated to boiling with vigorous stirring, to which a
trisodium citrate solution (5 mL, 1%) was then added. The
mixture was kept boiling for 1 h. Next, the solution was allowed
to cool to room temperature with continuous stirring.
As-prepared Ag NPs (20 mL) were then added to an aqueous
solution of meso-2,3-dimercaptosuccinic acid (DMSA) (2 mL,
0.2%) at pH 8.0 adjusted with NaOH. The obtained NPs were
then separated and puried by centrifugation at 13 000 rpm for
20 min and washed three times with ultrapure water to remove
the unbound DMSA. The resulting DMSA-modied Ag NPs were
suspended in ultrapure water (20 mL).
2.3 Preparation of PEG-modied GO
GO was prepared by vigorous oxidation of graphite according to
a modied Hummer's method.21,22 To impart biocompatibility
and physiological stability, GO was conjugated with amine-
terminated six-armed PEG molecules via EDC chemistry.23 The
obtained PEG-GO was puried by centrifugation and dialysis.
2.4 Synthesis of Ag–GO composites
Assembly of Ag NPs onto the GO surface was achieved by
chemical coupling of PEG-GO and DMSA-modied Ag NPs in
the presence of EDC (Fig. 1A). In our experiment, 2 mL aqueous
solution of PEG-GO (1.0 mg mL1) and 40 mg EDC were added
to 20 mL aqueous solution of Ag NPs. The mixed solution was
stirred at room temperature for 48 h, and then centrifuged at
13 000 rpm for 20 min, and washed with ultrapure water three10592 | Nanoscale, 2013, 5, 10591–10598times to remove the unbound GO and EDC. The resulting Ag–
GO was very stable in the cell medium. Formation of Ag–GO was
characterized by TEM. TEM images (Fig. 1B) were obtained
using a Tecnai G2 F20 S-Twin transmission electron
microscope.
To load DOX onto GO, 1 mL of doxorubicin hydrochloride
solution (2 mg L1 dissolved in water) was added to 10 mL
aqueous solution of Ag–GO which was rst adjusted to pH 8.0
with triethylamine in order to guarantee that more DOX can
adsorb on GO, before being stirred for 12 h in a dark room. The
free DOX was then removed by ultraltration through a 100 kDa
lter (Millipore) until the ltrate was nearly colorless. The
remaining Ag–GO/DOX solution was resuspended in ultrapure
water. The concentration of the nal DOX adsorbed on Ag–GO
was estimated by UV-vis spectroscopy. The concentration of
DOX was determined to be 131.7 mg mL1, and the loading
capacity of DOX on GO (the weight ratio of loaded drug to
carriers) was estimated to be 61.2%.
For confocal uorescence microscopy imaging, the Ag–GO
composites were labeled using uorescein isothiocyanate
(FITC) following the standard procedure: FITC (5 mg) was
added to ultrapure water (1 mL), the undissolved FITC was
removed by ltering, and the supernatant was added to 2 mL
aqueous solution of Ag–GO. The mixture was stirred for 12 h in
a dark room. Free FITC was removed by ultraltration through a
100 kDa lter until the ltrate was nearly colorless. The
remaining Ag–GO/FITC solution was resuspended in ultrapure
water.
2.5 Test of time-dependent drug release in aqueous solution
Ag–GO/DOX was dissolved in PBS and was characterized by UV-
vis spectroscopy. The solution was divided into four equal parts
and every part was acidied using drops of acetic acid until the
pH reached 5.0. Aer that it was stirred for several hours. The
four mixtures underwent ultraltration through a 100 kDa lter
and washed several times to remove the free DOX that detached
from the GO at 1 h, 2 h, 4 h and 6 h, respectively. The release
process was monitored by UV-vis spectroscopy.
2.6 Cell incubation with Ag–GO
The Ca Ski cell line (human cervical carcinoma cell) was
cultured in Dulbecco's modied eagle's medium (DMEM) with
10% fetal bovine serum (FBS). The cells were seeded in tissue
culture asks (about 3  105 cells) and incubated in a fully
humidied atmosphere at 37 C containing 5% CO2. For SERS
measurement, the cells were incubated on a glass slide over-
night at 37 C, then the culture medium was removed, and then
fresh medium and the Ag–GO composites were added to incu-
bate for 2 h and 6 h, respectively. Aer being washed with PBS
several times, the samples were ready for SERS measurement.
2.7 Raman imaging
All normal Raman and SERS imaging was performed using a
fast laser Raman imaging microscope (Raman-11, Nanophoton
Co.) with a 488 nm and 785 nm laser. The line-shaped laser spot
was illuminated on the sample via a combination cylindricalThis journal is ª The Royal Society of Chemistry 2013
Fig. 1 (A) Schematic illustration of synthesis of Ag–GO composites. (B) TEM image of the composites of Ag NPs adsorbed on graphene oxide (Ag–GO). (C) UV-vis
spectra of aqueous solution of (a) Ag NPs and (b) Ag–GO composites.
Fig. 2 UV-vis (A) and fluorescence (B) spectra of free DOX (a) and Ag–GO/DOX (b) in aqueous solution. Time-dependent drug-release at pH¼ 5.0. (C) UV-vis spectra of
Ag–GO/DOX in acidic solution for (a) 0 h, (b) 1 h, (c) 2 h, (d) 4 h and (e) 6 h, respectively. (D) Plot of Ct versus time for the release process.














































Fig. 3 (A) Bright field microscopic image of Ca Ski cells incubated with Ag–GO/
DOX. (B) SERS image produced by the Raman band of GO at 1326 cm1 (baseline
corrected), excited with a 785 nm laser. (C) Mean SERS spectra obtained at the













































View Article Onlinelens and line scanning optics. Raman scattering was detected by
using an oil-immersion objective (100, NA ¼ 1.4). For Raman
imaging, the line-focused laser was scanned by a galvanometer
mirror at the sample plane. The grating is 300 gr mm1. The
laser intensity at the sample plane is 0.1 mW mm2 and the
exposure time for each line is 1 s. The spectra were collected
from 200 to 6000 cm1.
Aer being washed with PBS several times, the cover glass
seeded with cells was put onto the sample stage (the side with
cells up), then another cover glass was placed on top of it. The
edges of the two cover glasses were further sealed using nail
polish. Aer that, the sample was ready for normal Raman and
SERS imaging.
2.8 Confocal uorescence microscopy
Ca Ski cells were seeded in a 6-well plate at a density of 2  105
cells per well in 2 mL culture medium for 12 h. Aer that, the
cells were incubated with Ag–GO/FITC for 3 h at 37 C. The cells
were then washed with DMEM. Finally, the DMEMwas replaced
with 2 mL Lyso-Tracker Red and incubated for a further 1 h at
37 C. Then the cells were rinsed with PBS and observed under a
laser confocal microscope (Nikon A1).
3 Results and discussion
3.1 Synthesis of Ag–GO
In this work, we prepared Ag–GO composites via chemical
conjugation (Fig. 1A). TEM image shows that the GO sheets
stack together, and that the Ag NPs (20 nm) formed aggregates
on the GO surface (Fig. 1B). The aggregation of the metal NPs10594 | Nanoscale, 2013, 5, 10591–10598usually leads to strong SERS enhancement of the probe
molecules.18
The binding of the Ag NPs to GO was also supported by UV-
vis spectroscopy (Fig. 1C). The broadening and red-shi of the
plasmon band of the Ag NPs in the Ag–GO composites, to that of
the corresponding isolated Ag NPs, indicate the formation of
the aggregated Ag NPs on the GO sheets, in agreement with the
TEM result.
The biological toxicity of materials will inuence the cell
survival. WST assay indicates that the cytotoxicity of the Ag–GO
(0.106 mM of Ag) was very low (Fig. S1 in the ESI†). Even though
the Ca Ski cells were incubated with Ag–GO for 24 h, the relative
cell viability rate still reaches 90%, indicating a very low cyto-
toxicity and good biocompatibility of Ag–GO.
3.2 Loading and release of anticancer drugs in an aqueous
solution
GO has a long-range p conjugation that can interact with
aromatic compounds via p–p stacking, which suggests poten-
tial applications as drug carriers.1–3 In our experiment, the anti-
cancer drug, DOX, was loaded onto GO via p–p interaction. The
free DOX was removed from the solution by repeated centrifu-
gation and ltration. UV-vis and uorescence spectra of the
resulting product were measured. The absorption peak at
499 nm and the emission peak at 584 nm suggest the formation
of Ag–GO/DOX composites (Fig. 2A and 2B). A red-shi of the
band due to DOX in the UV-vis spectra was observed aer it was
adsorbed on the Ag–GO composites (Fig. 2A). The quenching of
the uorescence of the DOX was observed aer adsorption on
Ag–GO (Fig. 2B), which is a result of the energy transfer between
the DOX and Ag–GO (Förster resonance energy transfer).24 In
our previous work, the loading ratio of DOX on GO could reach
400%,4 but in this experiment, the loading ratio of DOX on GO
is only 61%, due to the occupation of the surface sites of GO by
the Ag NPs.
DOX stacks onto GO via a p–p interaction. In PBS buffer,
which is nearly neutral, DOX is stable on the GO surface; when
the solution was adjusted to be more acidic, the amino group in
the DOX molecules can be ionized, and then the aqueous
solubility of DOX will increase, resulting in the detachment of
DOX from the GO surface. To conrm this, we did an in vitro
simulation experiment. Ag–GO/DOX was rst dispersed in the
acetic acid buffer (pH 5.0), then the solution was centrifuged
and the free DOX was washed off. Centrifuging the solution at
different times corresponded to different amounts of DOX
detached from the Ag–GO. Then, the UV-vis spectra of the
supernatant were recorded (Fig. 2C, spectra a–e). Our results
clearly show that the release of DOX from GO speeds up in the
acidic environment, with about 60% DOX released from the GO
surface aer 6 h in the acidic solution (Fig. 2D), whereas DOX
would not release from Ag–GO in PBS buffer.4
3.3 Tracking the intracellular localization of Ag–GO by SERS
In our previous work, we conrmed that the amount of Au–GO
uptake by Ca Ski cells reached the maximum at 6 h of incuba-
tion.18 So we also incubated the Ca Ski cells with Ag–GO/DOX forThis journal is ª The Royal Society of Chemistry 2013
Fig. 4 (A) Bright field microscopic image of Ca Ski cells incubated with Ag–GO/DOX. (B) SERS image obtained simultaneously by the 460 cm1 Raman band of DOX
(baseline corrected). (C) SERS image produced simultaneously by the 1595 cm1 Raman band of GO (baseline corrected). (D) Overlay of (B) and (C). (E) Mean SERS
spectra obtained at three different locations (white frames 1, 2 and 3) of (D). (F) Mean SERS spectra obtained at white frame 1 of (D) at different times. (G) Fluorescence














































View Article Online6 h. The bright eld image in Fig. 3A shows one Ca Ski cell aer
6 h of incubation with the Ag–GO/DOX. The SERS imaging was
performed using the 1326 cm1 band assigned to the D band of
GO (Fig. 3B). The results show that some GO was internalized by
the Ca Ski cell, and most of the GO was localized in the cyto-
plasm but not in the nucleus, which is consistent with the
observation in our previous work.18 Then we obtained the mean
SERS spectra which consisted of 25 spectra lines of two different
locations, respectively. One was from the cytoplasm (Fig. 3C,
curve 1), and the other was from the nucleus (Fig. 3C, curve 2).
The difference of the SERS spectra between the cytoplasm and
nucleus is obvious. In the cytoplasm, we obtained the SERS
spectra mostly from GO whereas we only obtained the Raman
spectra of nucleotide and base in the nucleus. The peak atThis journal is ª The Royal Society of Chemistry 20131144 cm1 corresponds to the ribose phosphate of nucleotides,
and the peaks at 1241 cm1 and 1353 cm1 are assigned to the
cytosine and adenine bases, respectively.25 All these data
suggest that GO did not enter the nucleus but only gathered in
the cytoplasm.3.4 Intracellular tracking of drug release from GO by SERS
To track the release process of DOX from the GO surface, Ca Ski
cells were cultured with Ag–GO/DOX for 2 h, washed with PBS
several times to remove physically adsorbed Ag–GO/DOX, and
then the Raman spectra were recorded. The bright eld image
of the Ca Ski cell incubated with Ag–GO/DOX for 2 h is shown in
Fig. 4A. We took the bands at 460 cm1 and 1595 cm1,Nanoscale, 2013, 5, 10591–10598 | 10595
Fig. 5 (A) SERS image produced using intensity of the Raman band of GO at 1590 cm1 (baseline corrected). (B) Fluorescence image produce by using 511 nm














































View Article Onlinecharacteristic of DOX and GO,26 to construct the SERS images,
respectively (Fig. 4B and 4C). Fig. 4D is the overlay of Fig. 4B and
4C, which indicates that the SERS spectra of DOX and GOmatch
well. We recorded the mean SERS spectra of three different
locations within one cell: one was from the cytoplasm (Fig. 4E,
curve 1), the second location was from nucleus (Fig. 4E, curve 2),
and the third spot was chosen from the substrate (Fig. 4E,
curve 3), which correspond to the white frames 1, 2, and 3 in
Fig. 4D, respectively. It can be seen from the two gures (Fig. 4D
and 4E) that the Ag–GO/DOX composites were taken up by the
Ca Ski cells aer incubation for 2 h, and most of the DOX was
still on the GO surface. Moreover, we can obtain the signals of
the carrier by SERS easily without any dye labeling. WeFig. 6 Confocal fluorescence images of Ca Ski cells incubated with Ag–GO/FITC for
microscopic image of Ca Ski cell, (B) Lyso-Tracker Red staining, (C) Ag–GO/FITC stain
10596 | Nanoscale, 2013, 5, 10591–10598performed SERS mapping of DOX using the band of 460 cm1
every 4 min. The mean SERS spectra of the DOX (white frame 1
in Fig. 4D) show that the SERS intensity decreased from 0min to
24 min (Fig. 4F), and the SERS signal of DOX disappeared at
28 min (Fig. 4F and S2 in the ESI†). This means that the amount
of DOX loaded on the GO surface decreased. We then studied
the mean uorescence spectra of DOX in the cytoplasm (white
frame 1 in Fig. 4G) and nucleus (white frame 2 in Fig. 4G). It was
found that the uorescence intensity of DOX both in the cyto-
plasm (Fig. 4H) and the nucleus (Fig. 4I) rst increased and then
reached its strongest at 16 min, and aer that the uorescence
was weakened. From this phenomenon we speculated that the
DOX was released from the GO surface, and then entered3 h, after which the lysosomes were stained with Lyso-Tracker Red. (A) Bright field
ing, and (D) overlay of (B) and (C). (Scale bar ¼ 50 mm.)













































View Article Onlinecytoplasm and nucleus during the time from 0 to 16 min.
Therefore, the originally quenched uorescence signal was
recovered aer DOX was released from the GO surface, resulting
in the increase in the uorescence intensity of DOX in both the
cytoplasm and the nucleus, and the decrease in the SERS
intensity of DOX. Aer that, the DOX uorescence may be
photobleached by continuous laser excitation,27 resulting in the
decrease of the uorescence intensity of DOX as well as
the SERS intensity of DOX, and the latter nally disappeared.
The uorescence of DOX in the nucleus was stronger than that
in the cytoplasm, conrming that most DOX entered nucleus
nally. We examined the uorescence intensity of the Ca Ski cell
before and aer incubation with Ag–GO using the same laser
intensity, and the data demonstrated that the autouorescence
of the Ca Ski cell was weak under our experimental conditions,
and this was also conrmed by the 3D image of living cells
(Fig. S3 in the ESI†).
Previous studies have conrmed that DOX absorbed on
carbon nanotubes can release in the intracellular lysosomes due
to the acidic environment in the lysosomes aer being delivered
into the cells.28 Our previous work indicates that GO is inter-
nalized by cells mainly through clathrin-mediated, energy-
dependent endocytosis, which would go through the
lysosomes.18 In order to conrm whether or not the DOX loaded
on GO will enter lysosomes and release from GO in lysosomes,
we dyed the lysosome with Lyso-Tracker Green aer incubation
of the Ca Ski cells with Ag–GO for 2 h. Fig. 5A shows the SERS
image obtained using the baseline corrected intensity of the GO
band at 1590 cm1. Fig. 5B is the uorescence image con-
structed by using the uorescence band of Lyso-Tracker Green
at 511 nm. Fig. 5C presents the overlay of Fig. 5A and 5B. The
three images show that almost all of the Ag–GO entered into the
lysosomes aer 2 h of incubation, resulting in the DOX release
from the GO surface. To conrm the SERS result, we employed
confocal uorescence microscopy to monitor the cellular
uptake process of Ag–GO and to verify whether or not it enters
into the lysosomes. In our experiment, Ag–GO was rst labeled
with uorescein isothiocyanate (FITC) by covalent conjugation.
Then the lysosomes were dyed with Lyso-Tracker Red aer
incubation of the Ca Ski cells with Ag–GO/FITC for 3 h. Merged
confocal microscope images of the Ca Ski cell showed a strong
green uorescence as well as red uorescence (Fig. 6), indi-
cating the Ag–GO/FITC was internalized in the lysosomes,
where efficient DOX release occurred. In addition, it was noted
that binding of FITC to Ag–GO leads to a lower zeta potential
(23.2 mV) than that of Ag–GO (15.7 mV), and thus it takes a
longer time (3 h) for Ag–GO/FITC to enter the cells than does
Ag–GO (2 h).
From the above results about the intracellular behavior of
drug-loaded GO, we can propose a mechanism of drug release
inside the cell. Firstly, the Ag–GO/DOX is taken up by cells
through endocytosis and then captured into the lysosomes;
aer that, due to the acidic environment in the lysosomes, DOX
starts to detach from the GO and escapes from the lysosomes to
the cytoplasm to yield free DOX. The free DOX inside the cyto-
plasm nally enters the nucleus, while GO, the drug vector,
mostly remains in the cytoplasm.This journal is ª The Royal Society of Chemistry 20134 Conclusions
We designed and synthesized the Ag–GO composite via covalent
conjugation, and employed it to study the release behavior of
anticancer drug DOX from GO carriers in living cells by means
of surface-enhanced Raman spectroscopy. Our results showed
that aer cellular uptake of DOX and Ag-loaded-GO, DOX was
released from GO inside the lysosomes, and then the free DOX
molecules entered into the nucleus, while the GO sheets were
trapped in the cytoplasm. The current work may provide insight
into the mechanisms of drug release from GO inside the living
cells, which may guide the future design of more efficient
GO-based drug delivery systems. Furthermore, we have
demonstrated that SERS offers distinct advantages over the
widely used uorescence technique in that it can provide direct
information on the carrier and the drug inside the living cells
simultaneously, and with no need for dye labeling.Acknowledgements
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